Apelin, on the other hand, can increase ACE2 levels in defective hearts and metabolize Ang II to produce the beneficial heptapeptide Ang- (1–7) as an anti-cardiac hypertrophy agent. The gene discussed is APLN; the disease is cardiac hypertrophy.